GI Windows Surgical
- Industry
- Medical Devices
- Founded Year
- 2012
- Headquarters
- Westwood, Massachusetts, United States
- Employee Count
- 23
Key People
-
Brian Tinkham - President and Chief Executive Officer
Email: brian.tinkham@giwindows.com
- Peter Lukin - Chief Operating Officer
- Christopher Thompson - Founder and Director
- Marvin Ryou - Co-Founder
Assessment
- Team
-
Aspect: Multiple successful MedTech entrepreneurs
Summary: The leadership team comprises experienced professionals with successful backgrounds in medical technology.
The presence of multiple successful MedTech entrepreneurs in the leadership team suggests a strong foundation for innovation and execution.
- Clinical Need
-
Aspect: Very Strong
Summary: The technology addresses a significant need for less invasive surgical procedures.
The development of less invasive surgical solutions aligns with the growing demand for procedures that reduce patient recovery time and healthcare costs.
- Competition
-
Aspect: First mover
Summary: The company is pioneering magnetic anastomosis technology with limited direct competition.
While leading the market offers advantages, it also involves risks associated with unproven market acceptance and the need for extensive education.
- Technical Challenge
-
Aspect: Moderate
Summary: The technology involves a moderate level of technical complexity.
Developing and commercializing magnetic anastomosis devices involves overcoming technical hurdles related to safety, efficacy, and regulatory compliance.
- Patent
-
Aspect: Strong
Summary: The company holds strong patents protecting its technology.
Robust intellectual property rights can deter competitors and attract investment by safeguarding the company's innovations.
- Financing
-
Aspect: Well-funded
Summary: The company has secured significant funding from reputable investors.
The $37 million Series B funding led by Orlando Health Ventures and participation from other strategic investors provides the necessary capital for clinical trials and market entry.
- Regulatory
-
Aspect: Pivotal Trial
Summary: The company is preparing for pivotal clinical trials.
Successful completion of pivotal trials is essential for obtaining regulatory clearance and demonstrating the safety and efficacy of the technology.
Opportunity Rollup
- Odds of Success
- 3.35
- Peak Market Share
- 3.9
- Segment CAGR
- 10.7%
- Market Segment
- General Surgery Devices
- Market Sub Segment
- Endoscopic Devices
| Year Post Launch | Market Penetration (%) |
|---|---|
| 1 | 0.19 |
| 2 | 0.58 |
| 3 | 1.36 |
| 4 | 2.73 |
| 5 | 3.90 |
Key Takeaway
GI Windows Surgical is well-positioned to capitalize on the growing demand for minimally invasive surgical solutions, supported by a strong team and substantial funding, though it faces challenges typical of pioneering medical technologies.